Nkarta Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.02

+0.10 (+5.21%)

As of Feb 8, 2:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +720.3% upside

Low Target $14.06

Average Target $16.57

High Target $23.26

Current Price $2.02

Current
$2.02

Target
$16.57

$14.06 $16.57 avg $23.26

Scenario Analysis

Bear Case

$14.06

596.0%

Low target

Base Case

$16.57

+720.3%

Avg target

Bull Case

$23.26

+1,051.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$23.03

-91.2% from high

52-Week Low

$10.85

+-81.4% from low

Target vs 52W High

$16.57

-28.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%